MedTrace Logo

A Double-Blind, Randomized, Double-Dummy, Active and Placebo-Controlled Clinical Study to Assess the Effect of an Oral Skin Supplement on Skin Health in Healthy Adults

NCT07740824 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-08-03

No results posted yet for this study

Summary

The aim of this study is to investigate the impact of a two skin from within nutritional supplement(s) compared to placebo on skin aging biomarker changes.

Conditions

  • Skin Aging

Interventions

DIETARY_SUPPLEMENT

Placebo SoftGel

The food supplement placebo (2 soft gels) will be consumed once per day with a large glass of water. Also, a supplement placebo powder will be provided to double-mask the 2 active products

DIETARY_SUPPLEMENT

Active SoftGel Supplement

The food supplement active supplement (2 soft gels) will be consumed once per day with a large glass of water. Also, a supplement placebo powder will be provided to double-mask the 2 active products

DIETARY_SUPPLEMENT

Active Comparator Powder

Active supplement comparator powder will be provided (20g) to be consumed once per day in a glass of water. The food supplement placebo (2 soft gels) will also be consumed once per day with a large glass of water to double-mask the trial.

DIETARY_SUPPLEMENT

Placebo Powder

Active supplement comparator powder will be provided (20g) to be consumed once per day in a glass of water.

Sponsors & Collaborators

  • MS Clinical Research Pvt. Ltd

    collaborator UNKNOWN

  • Amazentis SA

    lead INDUSTRY

Principal Investigators

  • Dr. Mukta Sachdev, MD · MS Clinical Research Pvt. Ltd

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-04
Primary Completion
2027-06-30
Completion
2027-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07740824 on ClinicalTrials.gov